FGF9 and coronary artery disorder: Recent studies [9] have suggested that it can inhibit apoptosis of ischemic and hypoxic myocardial cells together with the upregulation of fibroblast growth factor (FGF9), but its clinical value in coronary heart disease has not been elaborated.